EDIT: Just for perspective, Pharmaceutical products are the US’s 5th largest import, around a trillion dollar business right now
Just wanted to put it out there to fellow investors. I got an email today from an industry newsletter. The White House has an upcoming direct-to-consumer drug purchasing program that they’re dubbing TrumpRX 😂. The news is Pfizer is the first company to jump into it and they’re discounting some of their drugs (still expensive though cuz they’re brand name) from 50-85% in exchange for being exempt from Trump’s tariffs on pharmaceuticals made abroad for the next 3 years.
Take that what you may in your investing decisions.